Studies on both type 1 and type 2 diabetes have reported elevated enkephalin levels, with specific levels of [Met5]-enkephalin (i.e., OGF), the inhibitory growth factor that reduces cell replication, shown to be elevated in both animal and human models [23–26]. The gene discussed is PENK; the disease is type 2 diabetes mellitus.